![Pierre Langlade-Demoyen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Langlade-Demoyen active positions
Companies | Position | Start | End |
---|---|---|---|
Invectys SAS
![]() Invectys SAS Pharmaceuticals: MajorHealth Technology Invectys SAS is a French company that specializes in cancer immunotherapeutics. The private company is based in Paris, France and was founded in 2010 by Pierre Demoyen. The company focuses on blocking immunosuppressive pathways using monoclonal antibodies and cancer to maintain homeostasis in the immune system. The company's goal is to induce the production of cancer-specific antigens in the patient's body through DNA vaccines. François Lescure has been the CEO of the company since 2022. | Chairman | 2010-05-14 | - |
Career history of Pierre Langlade-Demoyen
Statistics
International
France | 2 |
Operational
Chairman | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Invectys SAS
![]() Invectys SAS Pharmaceuticals: MajorHealth Technology Invectys SAS is a French company that specializes in cancer immunotherapeutics. The private company is based in Paris, France and was founded in 2010 by Pierre Demoyen. The company focuses on blocking immunosuppressive pathways using monoclonal antibodies and cancer to maintain homeostasis in the immune system. The company's goal is to induce the production of cancer-specific antigens in the patient's body through DNA vaccines. François Lescure has been the CEO of the company since 2022. | Health Technology |